Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Transplantation Reviews (Orlando, Fla.)|March 23, 2011
Targeting the dysregulated mammalian target of rapamycin pathway in organ transplantation: killing 2 birds with 1 stoneMichael Haidinger, Johannes Werzowa, Thomas Weichhart, et al.
Trends in Biochemical Sciences|May 27, 2003
The STIR-domain superfamily in signal transduction, development and immunityMaria Novatchkova, Andreas Leibbrandt, Johannes Werzowa, et al.
Transplantation Reviews (Orlando, Fla.)|February 3, 2015
Antidiabetic therapy in post kidney transplantation diabetes mellitusJohannes Werzowa, Marcus Säemann, Michael Haidinger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 2011
Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patientsGerald Cohen, Jana Raupachova, Dalibor Ilic, et al.
Annals of Vascular Surgery|November 29, 2019
Primary External Stenting of an Autogenous Brachial-Basilic Upper Arm TranspositionChristoph Kuemmerli, Dominik Habrina, Stefan Puchner, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|June 24, 2008
Expression and regulation of HTRA1 during chick and early mouse developmentAnna Ferrer-Vaquer, Pablo Maurey, Johannes Werzowa, et al.
Journal of Musculoskeletal & Neuronal Interactions|June 13, 2019
Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)Barbara M Misof, Stéphane Blouin, Paul Roschger, et al.
Anticancer Research|February 5, 2009
mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivoDaniel Cejka, Matthias Preusser, Thorsten Fuereder, et al.
The Journal of Investigative Dermatology|November 5, 2010
Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivoJohannes Werzowa, Stefan Koehrer, Sabine Strommer, et al.
Clinical Transplants|June 24, 2011
Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case reportElisabeth Schwaiger, Heinz Regele, Markus Wahrmann, et al.
Pageof 5